Durvalumab Shows Activity in Patients who Progressed on Platinum-Based Chemo February 28, 2017Vol.40 No.02
Opdivo Demonstrated Improved Survival in Advanced Gastric Cancer in Phase III Study February 28, 2017Vol.40 No.02
Free Moonshot funds are not a substitute for sustained NCI funding, Lowy warns as prospect of year-long continuing resolution looms February 24, 2017Vol.43 No.08
Conversation with The Cancer LetterFree Marcia Crosse: This “failure of the adverse event reporting system” should serve as a “wake up call” February 24, 2017Vol.43 No.08By Matthew Bin Han Ong
Free GAO: Power morcellation is a unique case study in patient harmHundreds died over two decades as reporting requirements were ignored. February 24, 2017Vol.43 No.08By Matthew Bin Han Ong
Audit: Lynda Chin’s abandoned $62 million IBM Watson collaboration didn’t follow standard procedures February 17, 2017Vol.43 No.07By Paul Goldberg and Matthew Bin Han Ong
Free MMRF contributes largest disease-specific cancer genome dataset to NCI’s Genomic Data Commons February 10, 2017Vol.43 No.06By Matthew Bin Han Ong
